Condition

Takayasu Arteritis (TAK) clinical trials and research

As of November 12, 2026, Find a Trial lists 3 Takayasu Arteritis (TAK) clinical trials that are recruiting, at sites in 3 countries (most in United States (1), United Kingdom (1), Turkey (Türkiye) (1)). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.

Newest Takayasu Arteritis (TAK) clinical trials

StudyPhaseWhereStatusRegistered
Global Takayasu Arteritis Registry (GITA) — Istanbul, Istanbul and 1 other locations Recruiting Apr 30, 2026
Understanding patient and physician experiences and attitudes toward care in Takayasu arteritis. — Edinburgh Recruiting Jan 20, 2026
Registry for women with vasculitis during pregnancy — Tampa, Florida Recruiting Nov 2, 2015

All recruiting trials (3)

Related topics

CNS VasculitisEosinophilic Granulomatosis With Polyangiitis (EGPA)Granulomatosis With Polyangiitis (GPA)IgA VasculitisMicroscopic Polyangiitis (MPA)Takayasu ArteritisTakayasu's ArteritisVasculitis

Quick answers

How many Takayasu Arteritis (TAK) clinical trials are recruiting right now?

3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 3 countries. The most sites are in United States (1 trial), United Kingdom (1 trial), Turkey (Türkiye) (1 trial). Each study page lists its sites and which ones are recruiting.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →

Last reviewed 2026-11-12 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.